Number of the records: 1

protilátky monoklonálne humanizované

MeSH Tree Structures - protilátky monoklonálne humanizované

`[d12.776.124.486.485.114.224.060]`

aminokyseliny, peptidy a proteíny [d12] +
- proteíny [d12.776] +
  - proteíny krvné [d12.776.124] +
    - imunoproteíny [d12.776.124.486] +
      - imunoglobulíny [d12.776.124.486.485] +
        protilátky [d12.776.124.486.485.114] +
        protilátky monoklonálne [d12.776.124.486.485.114.224] +
        protilátky monoklonálne humanizované [d12.776.124.486.485.114.224.060]
        abciximab [d12.776.124.486.485.114.224.060.125]
        adalimumab [d12.776.124.486.485.114.224.060.250]
        alemtuzumab [d12.776.124.486.485.114.224.060.313]
        baziliximab [d12.776.124.486.485.114.224.060.344]
        bevacizumab [d12.776.124.486.485.114.224.060.375]
        brentuximab vedotin [d12.776.124.486.485.114.224.060.438]
        certolizumab pegol [d12.776.124.486.485.114.224.060.500]
        cetuximab [d12.776.124.486.485.114.224.060.750]
        daklizumab [d12.776.124.486.485.114.224.060.766]
        denosumab [d12.776.124.486.485.114.224.060.782]
        gemtuzumab [d12.776.124.486.485.114.224.060.790]
        inotuzumab ozogamicín [d12.776.124.486.485.114.224.060.794]
        ipilimumab [d12.776.124.486.485.114.224.060.798]
        natalizumab [d12.776.124.486.485.114.224.060.813]
        nivolumab [d12.776.124.486.485.114.224.060.829]
        omalizumab [d12.776.124.486.485.114.224.060.844]
        palivizumab [d12.776.124.486.485.114.224.060.860]
        panitumumab [d12.776.124.486.485.114.224.060.864]
        ramucirumab [d12.776.124.486.485.114.224.060.866]
        ranibizumab [d12.776.124.486.485.114.224.060.868]
        trastuzumab [d12.776.124.486.485.114.224.060.875] +
        ustekinumab [d12.776.124.486.485.114.224.060.937]
        protilátky monoklonálne myšie [d12.776.124.486.485.114.224.075] +
        terapeutiká protilátkové kombinované [d12.776.124.486.485.114.224.342]
        infliximab [d12.776.124.486.485.114.224.608]
        protilátky jednoreťazcové [d12.776.124.486.485.114.224.785]

`[d12.776.124.790.651.114.224.060]`

aminokyseliny, peptidy a proteíny [d12] +
- proteíny [d12.776] +
  - proteíny krvné [d12.776.124] +
    - globulíny sérové [d12.776.124.790] +
      - imunoglobulíny [d12.776.124.790.651] +
        protilátky [d12.776.124.790.651.114] +
        protilátky monoklonálne [d12.776.124.790.651.114.224] +
        protilátky monoklonálne humanizované [d12.776.124.790.651.114.224.060]
        abciximab [d12.776.124.790.651.114.224.060.125]
        adalimumab [d12.776.124.790.651.114.224.060.250]
        alemtuzumab [d12.776.124.790.651.114.224.060.375]
        baziliximab [d12.776.124.790.651.114.224.060.407]
        bevacizumab [d12.776.124.790.651.114.224.060.438]
        brentuximab vedotin [d12.776.124.790.651.114.224.060.469]
        certolizumab pegol [d12.776.124.790.651.114.224.060.500]
        cetuximab [d12.776.124.790.651.114.224.060.750]
        daklizumab [d12.776.124.790.651.114.224.060.766]
        denosumab [d12.776.124.790.651.114.224.060.782]
        gemtuzumab [d12.776.124.790.651.114.224.060.790]
        inotuzumab ozogamicín [d12.776.124.790.651.114.224.060.794]
        ipilimumab [d12.776.124.790.651.114.224.060.798]
        natalizumab [d12.776.124.790.651.114.224.060.813]
        nivolumab [d12.776.124.790.651.114.224.060.829]
        omalizumab [d12.776.124.790.651.114.224.060.844]
        palivizumab [d12.776.124.790.651.114.224.060.860]
        panitumumab [d12.776.124.790.651.114.224.060.864]
        ramucirumab [d12.776.124.790.651.114.224.060.866]
        ranibizumab [d12.776.124.790.651.114.224.060.868]
        trastuzumab [d12.776.124.790.651.114.224.060.875] +
        ustekinumab [d12.776.124.790.651.114.224.060.937]
        protilátky monoklonálne myšie [d12.776.124.790.651.114.224.075] +
        terapeutiká protilátkové kombinované [d12.776.124.790.651.114.224.306]
        infliximab [d12.776.124.790.651.114.224.537]

`[d12.776.377.715.548.114.224.200]`

aminokyseliny, peptidy a proteíny [d12] +
- proteíny [d12.776] +
  - globulíny [d12.776.377] +
    - globulíny sérové [d12.776.377.715] +
      - imunoglobulíny [d12.776.377.715.548] +
        protilátky [d12.776.377.715.548.114] +
        protilátky monoklonálne [d12.776.377.715.548.114.224] +
        protilátky monoklonálne humanizované [d12.776.377.715.548.114.224.200]
        abciximab [d12.776.377.715.548.114.224.200.125]
        adalimumab [d12.776.377.715.548.114.224.200.250]
        alemtuzumab [d12.776.377.715.548.114.224.200.375]
        baziliximab [d12.776.377.715.548.114.224.200.407]
        bevacizumab [d12.776.377.715.548.114.224.200.438]
        brentuximab vedotin [d12.776.377.715.548.114.224.200.469]
        certolizumab pegol [d12.776.377.715.548.114.224.200.500]
        cetuximab [d12.776.377.715.548.114.224.200.750]
        daklizumab [d12.776.377.715.548.114.224.200.766]
        denosumab [d12.776.377.715.548.114.224.200.782]
        gemtuzumab [d12.776.377.715.548.114.224.200.790]
        inotuzumab ozogamicín [d12.776.377.715.548.114.224.200.794]
        ipilimumab [d12.776.377.715.548.114.224.200.798]
        natalizumab [d12.776.377.715.548.114.224.200.813]
        nivolumab [d12.776.377.715.548.114.224.200.829]
        omalizumab [d12.776.377.715.548.114.224.200.844]
        palivizumab [d12.776.377.715.548.114.224.200.860]
        panitumumab [d12.776.377.715.548.114.224.200.864]
        ramucirumab [d12.776.377.715.548.114.224.200.866]
        ranibizumab [d12.776.377.715.548.114.224.200.868]
        trastuzumab [d12.776.377.715.548.114.224.200.875] +
        ustekinumab [d12.776.377.715.548.114.224.200.937]
        protilátky monoklonálne myšie [d12.776.377.715.548.114.224.284] +
        terapeutiká protilátkové kombinované [d12.776.377.715.548.114.224.463]
        infliximab [d12.776.377.715.548.114.224.642]

subject heading

subject heading

Number of the records: 1

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.